Anti-EMC10/ C19orf63/ HSM1 functional antibody

Anti-EMC10/ C19orf63/ HSM1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to EMC10/EMC10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0173-Ab-1/ GM-Tg-hg-SE0173-Ab-2Anti-Human EMC10 monoclonal antibodyHuman
GM-Tg-rg-SE0173-Ab-1/ GM-Tg-rg-SE0173-Ab-2Anti-Rat EMC10 monoclonal antibodyRat
GM-Tg-mg-SE0173-Ab-1/ GM-Tg-mg-SE0173-Ab-2Anti-Mouse EMC10 monoclonal antibodyMouse
GM-Tg-cynog-SE0173-Ab-1/ GM-Tg-cynog-SE0173-Ab-2Anti-Cynomolgus/ Rhesus macaque EMC10 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0173-Ab-1/ GM-Tg-felg-SE0173-Ab-2Anti-Feline EMC10 monoclonal antibodyFeline
GM-Tg-cang-SE0173-Ab-1/ GM-Tg-cang-SE0173-Ab-2Anti-Canine EMC10 monoclonal antibodyCanine
GM-Tg-bovg-SE0173-Ab-1/ GM-Tg-bovg-SE0173-Ab-2Anti-Bovine EMC10 monoclonal antibodyBovine
GM-Tg-equg-SE0173-Ab-1/ GM-Tg-equg-SE0173-Ab-2Anti-Equine EMC10 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0173-Ab-1/ GM-Tg-hg-SE0173-Ab-2; GM-Tg-rg-SE0173-Ab-1/ GM-Tg-rg-SE0173-Ab-2;
GM-Tg-mg-SE0173-Ab-1/ GM-Tg-mg-SE0173-Ab-2; GM-Tg-cynog-SE0173-Ab-1/ GM-Tg-cynog-SE0173-Ab-2;
GM-Tg-felg-SE0173-Ab-1/ GM-Tg-felg-SE0173-Ab-2; GM-Tg-cang-SE0173-Ab-1/ GM-Tg-cang-SE0173-Ab-2;
GM-Tg-bovg-SE0173-Ab-1/ GM-Tg-bovg-SE0173-Ab-2; GM-Tg-equg-SE0173-Ab-1/ GM-Tg-equg-SE0173-Ab-2
Products NameAnti-EMC10 monoclonal antibody
Formatmab
Target NameEMC10
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EMC10 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0173-Ag-1Recombinant multi-species EMC10/ C19orf63/ HSM1 protein


    Target information

    Target IDGM-SE0173
    Target NameEMC10
    Gene ID284361,69683,292878,719285,484362,101085509,507692,100062997
    Gene Symbol and Synonyms2310044H10Rik,5430410O10Rik,C18H19orf63,C19H19orf63,C19orf63,C1H19orf63,EMC10,HSM1,HSS1,Inm02,Mirta22,NEDDFAS
    Uniprot AccessionQ5UCC4,Q6AYH6,A1A4M2
    Uniprot Entry NameEMC10_HUMAN,EMC10_RAT,EMC10_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000161671
    Target ClassificationN/A

    The target: EMC10, gene name: EMC10, also named as C19orf63, HSM1, HSS1. Contributes to membrane insertase activity. Involved in positive regulation of angiogenesis; positive regulation of endothelial cell proliferation; and protein insertion into ER membrane. Located in extracellular region. Is integral component of endoplasmic reticulum membrane. Part of EMC complex. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.